WilsonWRSchuknechtHF. Update on the use of streptomycin therapy for Meniere's disease. Am J Otol1980;2:108–11.
2.
BeckC.Intratympanic application of gentamicin for treatment of Meniere's disease. Keijo J Med1986;35:36–41.
3.
LangmanAWKeminkJLGrahamMD. Titration streptomycin therapy for bilateral Meniere's disease: follow-up report. Ann Otol Rhinol Laryngol1990;99:923–6.
4.
LundyL.GrahamMD. Ototoxicity and otopicals medications: a survey of otolaryngologists. Am J Otol1993;14:141–6.
5.
WrightCGMeyerhoffWLHalamaAR. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol1987;8:495–9.
6.
IkedaK.MorizonoT.Round window membrane permeability during experimental purulent otitis media: altered cortisporin ototoxicity. Ann Otol Rhinol Laryngol1990;99:46–8.
ThomasJ.MarionMSHinojosaR.Neomycin ototoxicity. Am J Otolaryngol1992;13:54–5.
11.
MyersonM.KnoghtHGGambariniAJIntrapleural neomycin causing ototoxicity. Ann Thorac Surg1970;9:483–6.
12.
JohnsonCA. Hearing loss following the application of topical neomycin. J Burn Care Rehabil1988;9:162–4.
13.
MorrellP.HeyE.MackeeIWDeafness in preterm baby associated with topical antibiotic spray containing neomycin. Lancet1985;1:1167–8.
14.
KellyDRNiloERBerggrenRB. Deafness after topical neomycin wound irrigation. N Engl J Med1969;280:1338–9.
15.
BerkDPChalmersT.Deafness complicating antibiotic therapy of hepatic enephalopathy. Ann Intern Med1970; 73: 393–6.
16.
WardKMRounthwaiteFJ. Neomycin ototoxicity. Ann Otol Rhinol Laryngol1978;87:211–5.
17.
KalbianW.Deafness following oral use of neomycin. South Med J1972;65:499–501.
18.
GreenbergLHMomaryH.Audiotoxicity and nephrotoxicity due to orally administered neomycin. JAMA1965;194:237–8.
19.
KingJT. Severe deafness in an infant following oral administration of neomycin. J Med Assoc Ga1962;51:530–1.
20.
RubenRJDalyJF. Neomycin ototoxicity and nephrotoxicity. A case report following oral administration. Laryngoscope1968; 78: 1734–7.
21.
KavanaghKTMcCabeBF. Ototoxicity of oral neomycin and vancomycin. Laryngoscope1983;93:649–53.
22.
GibsonWSJr.Deafness due to orally administered neomycin. Arch Otolaryngol1967;86:163–5.
23.
HalpernEBHellerMF. Ototoxicity of orally administered neomycin. Arch Otolaryngol1961;73:675–7.
24.
WaisbrenBASpinkWW. A clinical appraisal of neomycin. Ann Intern Med1950;33:1099–119.
25.
PothEJFrommSMWiseRINeomycin, a new intestinal antiseptic. Tex Rep Biol Med1950;8:353–60.
26.
KuninCMChalmersTCLeevyCM. Absorption of orally administered neomycin and kanamycin: with special reference to patients with severe hepatic and renal disease. N Engl J Med1960;262:380–5.
27.
PothEJ. Intestinal antisepsis in surgery. JAMA1953; 153: 1516–21.
28.
LastPMSherlockS.Systemic absorption of orally administered neomycin in liver disease. N Engl J Med1960; 262: 385–9.
29.
ReedCEWellmanEA. Staphylococcic endocarditis treated with neomycin: report of a case. JAMA1953;152:702–3.
30.
HuizingEHDe GrootJCMJ. Human cochlear pathology in aminoglycoside ototoxicity—a review. Acta Otolaryngol (Stockh)1987;(suppl 436):117–25.
31.
KausS.The influence of calcium on the ototoxicity of aminoglycosides. Acta Otolaryngol (Stockh)1992;112:83–7.
32.
WilliamsSEZennerHPSchachtJ.Three molecular steps of aminoglycoside ototoxicity demonstrated in outer hair cells. Hear Res1987;30:11–8.
33.
DuncanGGClancyCFWolgamotJRNeomycin: results of clinical use in ten cases. JAMA1951; 145: 75–80.
34.
LeachW.Ototoxicity of neomycin and other antibiotics. J Laryngol Otol1962;76:774–90.
35.
RappaportBZFaustiSASchechterMAA prospective study of high-frequency auditory function in patients receiving oral neomycin. Scand Audiol1986;15:67–71.
36.
HermansPEWilhelmMP. Vancomycin. Mayo Clin Proc1987;62:901–5.
37.
TedescoF.MarkhamR.GurwithM.Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet1978;2:226–8.
